"We started off with 20 grams of it worth $20," James Wood, a 17-year-old student, told The Age. "We ended up with $37,000 worth of Daraprim."
The students and organization they worked with, University of Sydney's Open Source Malaria Consortium, were transparent that this was a reaction to the predatory pharmaceutical pricing of which Shkreli has become the symbol.
Despite the public backlash, Daraprim still costs $375. The scandal, along with the ongoing Theranos affair and the EpiPen price hike, are among the biggest public health outrages of the last two years. But the efforts of a few Aussie teens go to show that if you try to make drugs affordable, it can be done... as long as you want to do it.
"I personally think it's ethically wrong to place a profit over the welfare of people," Wood says.
Shkreli's reaction to the backlash he faced over his price gouging was far from gracious. He called journalists morons, claimed his actions weren't greedy at all but "altruistic," hurled insults online, and badgered women on Twitter.